WUXI BIO (02269) announced that it cancelled 39.8245 million repurchased shares on September 18, 2026.

The cancellation involves shares previously bought back by the company as part of its ongoing capital management strategy.

Following the cancellation, the company's total issued share capital will be reduced accordingly, reflecting the latest corporate action.